MedPath

Clinical trial to assess efficacy of uttarbasti in the management of urethral stricture.

Phase 3
Conditions
Health Condition 1: N359- Urethral stricture, unspecified
Registration Number
CTRI/2024/06/068553
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Male Patients aged 20- 80 years.

2. Subject diagnosed as Urethral stricture by clinical and investigative methods will be

selected.

3. In uroflowmetry Qmax 3- 20 ml/s should be included.

4. ICD guidelines for urethral stricture 2024 ICD-10-CM Diagnosis Code N35.91 will

be considered

Exclusion Criteria

1,Patients having other systemic pathology like Tuberculosis, Renal Failure,

Uncontrolled Diabetes Mellitus And Uncontrolled Hypertension Etc..

2. Patients having other urinary system pathology like severe, Nephrolithiasis,

BPH(Grade 3), Prostatitis

3. Patients suffering from neoplasm of urinary tract.

4. Patients having congenital deformity of urogenital tract

5. HIV and HBsAg positive patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath